Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary <i>sequelae</i> after COVID-19 Infection.

导出 OA

翻译打印收藏纠错

作者： Valentina,Ruggiero ^[1] ; Rita P,Aquino ^[2] ; Pasquale,Del Gaudio ^[1] ; Pietro,Campiglia ^[1] ; Paola,Russo ^[1]

作者单位： Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy. ^[1] PhD Program in Drug Discovery and Development, University of Salerno, 84084 Fisciano, Italy. ^[2]

关键词 in vitro lung models inhalation therapy long COVID post-COVID fibrosis post-COVID sequelae post-COVID syndrome

DOI 10.3390/pharmaceutics14061135

PMID 35745708

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Pharmaceutics

2022年14卷6期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary <i>sequelae</i> after COVID-19 Infection.

Pharmaceutics

相似文献

Pharmaceutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary <i>sequelae</i> after COVID-19 Infection.

Pharmaceutics

相似文献

Pharmaceutics

相关期刊

检索历史清除